FIELD: medicine.
SUBSTANCE: invention concerns derivatives of a misinformation (B30) human insulin which have lateral a chain, attached to ε-amino group of the rest of the lysine which is present at the B-chain of initial insulin where this lateral the chain has the general formula: -W-X-Y-Z where W, X, Y and Z are such as it is defined in the description.
EFFECT: increased efficiency.
15 cl, 4 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN DERIVATIVES | 2004 |
|
RU2518460C2 |
| TREATING DIABETES MELLITUS BY INSULIN INJECTIONS AS LITTLE AS ONCE DAY | 2009 |
|
RU2540922C2 |
| PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2670106C2 |
| METHOD OF OBTAINING INSULIN ZINC COMPLEXES | 2011 |
|
RU2572214C2 |
| METHOD OF CONJUGATING PEPTIDES, MEDIATED BY TRANSGLUTAMINASE | 2005 |
|
RU2385879C2 |
| INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
| ACYLATED INSULIN ANALOGUES STABILISED WITH RESPECT TO PROTEASES | 2009 |
|
RU2571857C2 |
| PEPTIDE COMPOSITION CONTAINING PROPYLENE GLYCOL OPTIMAL FOR MANUFACTURING AND APPLICATION IN INJECTION DEVICES | 2004 |
|
RU2421238C2 |
| INSULIN CONJUGATES | 2019 |
|
RU2809189C2 |
| INSULIN PURIFICATION | 2012 |
|
RU2603752C2 |
